NCT01634958 - Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma | Biotech Hunter

Enrollment

308

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent AsthmaSensitization Against Phleum Pratense PollenDose-Finding Study

Interventions

BIOLOGICAL

Depigoid Phleum

Suspension for subcutaneous injection Build-up phase (day 1): 0,1mL + 0,2mL + 0,2mL s.c.injections in intervals of 30 minutes Maintenance phase: 5x single s.c. injection of 0,5mL every 4 weeks

Trial Locations (2)

10117

Hippke, Ear-Nose-Throat specialist, Berlin

65183

Zentrum für Rhinologie und Allergie, Wiesbaden